Spinal Cord MRI in Clinically Isolated Optic Neuritis
JNNP 74:1577-1580, Dalton,C.M.,et al, 2003

Multiple Sclerosis Presenting as Lower Motor Neuron Wasting and Weakness of the Distal Upper Extremity
Neurol 61:1303-1304, Chong,P.S.T.,et al, 2003

Smoking is a Risk Factor for Multiple Sclerosis
Neurol 61:1122-1124, Riise,T.,et al, 2003

Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003

MR Features of Diseases Involving Bilateral Middle Cerebellar Peduncles
AJNR 24:1946-1954, Okamoto,K.,et al, 2003

Dirty-Appearing White Matter in Multiple Sclerosis: Volumetric MR Imaging and Magnetization Transfer Ratio Histogram Analysis
AJNR 24:1935-1940,1929, Ge,Y.,et al, 2003

Vasculitis of the Spinal Cord
Arch Neurol 60:1791-1794, Ropper,A.H.,et al, 2003

A Longitudinal Study of Brain Volume Changes in Normal Aging Using Serial Registered Magnetic Resonance Imaging
Arch Neurol 60:989-994, Scahill,R.I.,et al, 2003

High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis
Arch Ophthalmol 121:944-949, Optic Neuritis Study Group, 2003

Pain in Patients with Multiple Sclerosis
Arch Neurol 60:1089-1094, Svendsen,K.B.,et al, 2003

Validation of Diagnositc Magnetic Resonance Imaging Criteria for Multiple Sclerosis and Response to Interferon B1a
Ann Neurol 53:718-724, Barkhof,F.,et al, 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Acupuncture in Clinical Neurology
The Neurologist 9:137-148, Rabinstein,A.A. &Shulman,L.M., 2003

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003

Cognitive Presentation of Multiple Sclerosis: Evidence for a Cortical Variant
JNNP 74:872-877, Zarei,M.,et al, 2003

A Randomized Controlled Study of the Acute and Chronic Effects of Cooling Therapy for MS
Neurol 60:1955-1960, NASA/MS Cooling Study Group, 2003

Hippocampal Sclerosis Is a Progressive Disorder: A Longitudinal Volumetric MRI Study
Ann Neurol 53:413-416, Fuerst,D.,et al, 2003

Neuromyelitis Optica:What It Is and What It Might Be
Lancet 361:889-890, Weinshenker,B.G., 2003

Rasmussen's Encephalitis
Neurol 60:422-425, Granata,T.,et al, 2003

Multiple Sclerosis and Epstein-Barr Virus
JAMA 289:1533-1536, Levin,L.I.,et al, 2003

Three Subsequent Single Doses of Gadolinum Chelate for Brain MR Imaging in Multiple Sclerosis
AJNR 24:658-662, Sardanelli,F.,et al, 2003

New T2 Lesions Enable an Earlier Diagnosis of Multiple Sclerosis in Clinically Isolated Syndromes
Ann Neurol 53:673-676, Dalton,C.M.,et al, 2003

Concurrence of Multiple Sclerosis and Intracranial Glioma. Report of a Case and Review of the Literature.
Clin Neuropathol 22:304-308, Shuangshoti,S.,et al, 2003

Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003

Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003

Constipation in Neurological Diseases
JNNP 74:13-19, Winge,K.,et al, 2003

New Diagnostic Criteria for Multiple Sclerosis
Neurol 60:27-30,6, Tintore,M.,et al, 2003

Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002

Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002

Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002

Course and Prognosis in Early-Onset MS
Neurol 59:1922-1928, Simone,I.L., etla, 2002

Prognosis for Gross Motor Function in Cerebral Palsy
JAMA 288:1357-1363,1399, Rosenbaum,P.L., et al, 2002

A Blinding Combination
Lancet 360:1220, Matthews,B.N.,et al, 2002

Tourette's Syndrome
Lancet 360:1577-1586, Leckman,J.F., 2002

A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002

Cause and Prognosis of Nontraumatic Sixth Nerve Palsies in Young Adults
Ophthalmology 109:1925-1928, Peters III,G.B.,et al, 2002

Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002

Interferon Beta-1a for Early Multiple Sclerosis: CHAMPS Trial Subgroup Analyses
Ann Neurol 51:481-490, Beck,R.W.,et al, 2002

Acquired Sexual Parphilia in Patients with Multiple Sclerosis
Arch Neurol 59:1006-1010, Frohman,E.M.,et al, 2002

Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002

Bacterial Infection as a Cause of Multiple Sclerosis
Lancet 360:352-353, Wolfson,C. &Talbot,P., 2002

Nonmotor Fluctuations in Parkinson's Disease
Neurol 59:408-413, Witjas,T.,et al, 2002

Progressive Ventricular Enlargement in Patients with Clinically Isolated Syndromes is Associated with the Early Development of Multiple Sclerosis
JNNP 73:141-147, Dalton,C.M.,et al, 2002

Lesions of the Corpus Callosum: MR Imaging and Differential Considerations in Adults and Children
AJR 179:251-257, Bourekas,E.C.,et al, 2002

Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS
Neurol 59:636-639, Pollmann,W.,et al, 2002

Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002

Is a "Vanishing Tumor" Always a Lymphoma?
Neurol 59:762-764, Bromberg,J.E.C.,et al, 2002

Proton MR Spectroscopy of Tumefactive Demyelinating Lesions
AJNR 23:1378-1386, Saindane,A.M.,et al, 2002

Acute Disseminated Encephalomyelitis
Neurol 59:1224-1231, Tenembaum,S.,et al, 2002